TOKENPOST
1 min read
Add as a preferred source on Google

Sionna Therapeutics Reports $0.72 Net Loss Per Share for Q3

The figure covers both basic and diluted per-share results. The quarter ended Sept. 30, 2026.

By John Kim
Published
An unmarked steel oil barrel against a warm neutral backdrop / TokenPost.ai
An unmarked steel oil barrel against a warm neutral backdrop / TokenPost.ai

Sionna Therapeutics recorded net loss per share, basic and diluted, of $0.72 for the third quarter ended Sept. 30, 2026. The company’s results release is dated Nov. 10, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…